IMMP
Immutep LTD ADR

8,873
Mkt Cap
$421.48M
Volume
147,478.00
52W High
$3.53
52W Low
$1.32
PE Ratio
-10.52
IMMP Fundamentals
Price
$2.86
Prev Close
$2.73
Open
$2.72
50D MA
$2.60
Beta
0.71
Avg. Volume
196,476.50
EPS (Annual)
-$0.2733
P/B
4.44
Loading...
Loading...
Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alfa (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731). The company was founded on May 21, 1987 and is headquartered in Sydney, Australia.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Immutep Limited - ADR?
What is the 52-week high for Immutep Limited - ADR?
What is the 52-week low for Immutep Limited - ADR?
What is Immutep Limited - ADR stock price today?
What was Immutep Limited - ADR stock price yesterday?
What is the PE ratio of Immutep Limited - ADR?
What is the Price-to-Book ratio of Immutep Limited - ADR?
What is the 50-day moving average of Immutep Limited - ADR?

Latest IMMP News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.